Vicor Corp

CEO Patrizio’s recent 10(b)(5) sales at Vicor show a strategic liquidity‑first approach, not a confidence drop, keeping insider ownership strong while the company’s power‑components rally remains bullish.

Vicor Corp insider trading revealed: VP HR bought 323 shares at $75.43, sold 323 at $355, and liquidated options—signaling short‑term gains and possible market impact.

Insider buy at $33.96 shows executive confidence amid mixed selling and a 29.6% weekly rally—watch for future sales before earnings or product launches.

Vicor insider trading shows VP Robert Gendron’s buy‑sell‑buy‑sell moves, hinting at confidence in the company’s AI power‑chip growth and recent Q2 upside.

Insider D’Amico’s $50 buy at Vicor Corp suggests hidden upside as the company ramps up revenue guidance, licensing deals, and AI‑powered power tech—watch for dilution, price action, and potential rally.

Insider trading insights: Andrew D’Amico’s $50 purchase of Vicor Corp shares amid a flurry of short‑term sales—what this means for investors and future buying chances.

Vicor insider sales trend: Alex Gusinov’s 1,502‑share sell at $300 shows routine rebalancing amid a 12% weekly gain and $315 52‑week high. Investors stay focused on Vicor’s solid fundamentals, not a bearish warning.

Insightful look at Vicor Corp’s insider trading: why Andrew D’Amico’s buy‑sell pattern matters for investors, and what it means for the company’s future.

CEO Vinciarelli Patrizio gifts 3,500 Vicor shares to hospitals, boosting ESG profile while maintaining insider confidence amid strong stock performance.

Vicor insider trading reveals strategic liquidity moves, confirming leadership confidence and long‑term growth prospects.